The livers of the T2DM + SFFE + brusatol-treated rats exhibited a significant increase in the levels of MDA, parallel with a significant decrease in the levels of GSH, SOD, and HO-1, as compared with the T2DM + SFFE-treated rats (Figure 3A–D). This evidence concerns the gene HMOX1 and type 2 diabetes mellitus.